Tivozanib Approval Adds to the Armamentarium in Relapsed/Refractory Advanced RCC,

… chief of Clinical Trials at Vanderbilt-Ingram Cancer Center, discussed the unique … It is an older drug and was the first TKI approved [in RCC]., … chief of Clinical Trials at Vanderbilt-Ingram Cancer Center, discussed the unique … It is an older drug and was the first TKI approved [in RCC]., Read More

Scroll to Top